Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
22 08 2023
22 08 2023
Historique:
accepted:
04
06
2023
received:
23
01
2023
medline:
14
8
2023
pubmed:
16
6
2023
entrez:
16
6
2023
Statut:
ppublish
Résumé
The functionality of natural killer (NK) cells is tuned during education and is associated with remodeling of the lysosomal compartment. We hypothesized that genetic variation in killer cell immunoglobulin-like receptor (KIR) and HLA, which is known to influence the functional strength of NK cells, fine-tunes the payload of effector molecules stored in secretory lysosomes. To address this possibility, we performed a high-resolution analysis of KIR and HLA class I genes in 365 blood donors and linked genotypes to granzyme B loading and functional phenotypes. We found that granzyme B levels varied across individuals but were stable over time in each individual and genetically determined by allelic variation in HLA class I genes. A broad mapping of surface receptors and lysosomal effector molecules revealed that DNAM-1 and granzyme B levels served as robust metric of the functional state in NK cells. Variation in granzyme B levels at rest was tightly linked to the lytic hit and downstream killing of major histocompatibility complex-deficient target cells. Together, these data provide insights into how variation in genetically hardwired receptor pairs tunes the releasable granzyme B pool in NK cells, resulting in predictable hierarchies in global NK cell function.
Identifiants
pubmed: 37327114
pii: 496303
doi: 10.1182/bloodadvances.2023009827
pmc: PMC10440473
doi:
Substances chimiques
Granzymes
EC 3.4.21.-
Receptors, KIR
0
Histocompatibility Antigens Class I
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4492-4504Subventions
Organisme : NIAID NIH HHS
ID : R01 AI151549
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI158410
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA111412
Pays : United States
Informations de copyright
© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
J Exp Med. 2005 Apr 4;201(7):1145-55
pubmed: 15809355
Science. 2011 Oct 7;334(6052):89-94
pubmed: 21868630
Immunogenetics. 2020 Feb;72(1-2):49-55
pubmed: 31641782
Sci Signal. 2011 Apr 05;4(167):ra21
pubmed: 21467299
Cell Rep. 2019 Nov 19;29(8):2284-2294.e4
pubmed: 31747601
Annu Rev Immunol. 2005;23:225-74
pubmed: 15771571
Nat Commun. 2017 May 31;8:15627
pubmed: 28561023
PLoS Comput Biol. 2021 Aug 2;17(8):e1008904
pubmed: 34339413
Am J Hum Genet. 2016 Aug 4;99(2):375-91
pubmed: 27486779
Philos Trans R Soc Lond B Biol Sci. 2012 Mar 19;367(1590):800-11
pubmed: 22312047
Lancet. 2000 Nov 25;356(9244):1795-9
pubmed: 11117911
Cancer Immunol Res. 2018 Apr;6(4):467-480
pubmed: 29459477
Bone Marrow Transplant. 2020 Jan;55(1):12-24
pubmed: 30833742
J Exp Med. 2010 Sep 27;207(10):2065-72
pubmed: 20819928
Nature. 1998 Feb 19;391(6669):795-9
pubmed: 9486650
J Immunol. 2021 Feb 15;206(4):849-860
pubmed: 33441440
Sci Signal. 2018 Feb 13;11(517):
pubmed: 29440510
Nat Rev Immunol. 2008 Sep;8(9):713-25
pubmed: 19172692
Nat Commun. 2019 Jan 31;10(1):514
pubmed: 30705279
Blood. 2008 Sep 15;112(6):2369-80
pubmed: 18583565
Immunol Rev. 2015 Sep;267(1):178-96
pubmed: 26284478
Immunity. 2016 Aug 16;45(2):280-91
pubmed: 27496730
J Immunol. 2013 Mar 15;190(6):2880-5
pubmed: 23390293
AIDS. 2015 Jul 31;29(12):1433-43
pubmed: 26244383
Blood. 2009 Mar 12;113(11):2434-41
pubmed: 18974374
Sci Signal. 2021 Nov 09;14(708):eabe5380
pubmed: 34752140
J Immunol. 2015 May 1;194(9):4518-27
pubmed: 25825444
Blood. 2013 Apr 4;121(14):2678-88
pubmed: 23325834
J Immunol. 2022 Jan 15;208(2):492-500
pubmed: 34937746
J Immunol. 2012 Aug 1;189(3):1418-30
pubmed: 22772445
J Exp Med. 2016 May 2;213(5):791-807
pubmed: 27045007
J Allergy Clin Immunol Pract. 2022 Jul;10(7):1763-1775
pubmed: 35561968
PLoS Genet. 2015 Aug 20;11(8):e1005439
pubmed: 26292085
Immunity. 2006 Aug;25(2):331-42
pubmed: 16901727
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3053-8
pubmed: 18287063
J Immunol. 2016 Nov 15;197(10):4127-4136
pubmed: 27798146
Trends Immunol. 2009 Apr;30(4):143-9
pubmed: 19282243
Nat Rev Immunol. 2010 Oct;10(10):724-34
pubmed: 20818413
J Immunol. 2008 Mar 15;180(6):3969-79
pubmed: 18322206
J Immunol. 2013 Oct 15;191(8):3981-5
pubmed: 24038086
Sci Immunol. 2016 Sep;1(3):
pubmed: 27868107
J Immunol. 2016 Apr 15;196(8):3398-410
pubmed: 26962229
J Immunol. 2015 Oct 1;195(7):3160-70
pubmed: 26311903
J Immunol. 2015 Oct 1;195(7):3374-81
pubmed: 26320254
J Immunol. 1998 May 15;160(10):4951-60
pubmed: 9590243
Blood. 2010 Nov 11;116(19):3853-64
pubmed: 20696944
Elife. 2017 Sep 06;6:
pubmed: 28875936
Nat Rev Immunol. 2013 Feb;13(2):133-44
pubmed: 23334245
Curr Biol. 1998 Jan 1;8(1):1-10
pubmed: 9427624
J Immunol. 2013 Jun 15;190(12):6198-208
pubmed: 23686481
Blood. 2013 Jun 6;121(23):4703-7
pubmed: 23637128
Nat Genet. 2007 Jun;39(6):733-40
pubmed: 17496894
Immunol Rev. 2015 Sep;267(1):197-213
pubmed: 26284479
Cancer Immunol Res. 2018 Dec;6(12):1537-1547
pubmed: 30242020